Shares in Spectrum Pharmaceuticals (SPPI) jumped 71% in extended trading after announcing positive topline results from a Phase 2 clinical trial evaluating its …
Penny stocks give a whole new meaning to risk/reward plays. These tickers can witness explosive movements in the blink of an eye, giving …
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) just riled up Wall Street today with enticing Phase 2 study results in non-small cell lung cancer (NSCLC), sending …
Edward White sees positive road ahead after SPPI’s compelling cancer asset hits ORR of 73% in Exon 20.
Spectrum Pharmaceuticals, Inc.(NASDAQ:SPPI) is a mover and shaker out on the Street today, with investors sparking the stock on an almost 50% upturn.
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) is dealing with the rejection from yesterday’s FDA Oncology Advisory Committee meeting for its pipeline drug Qapzola (apaziquone), designed …
Analysts are weighing in on the controversial drug giant Valeant Pharmaceuticals Intl Inc (NYSE:VRX), NY-based drug company Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and NV-based pharma company …
H.C.
In a research report released Monday, H.C.
In a research report published Friday, H.C.
